Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models

Synchronized cycles of bacterial lysis for in vivo delivery

(2016) M. Omar Din et al.   NATURE

Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes

(2015) Franklin F. Duan et al.   DIABETES

A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics

(2015) Matthew J Renwick et al.   JOURNAL OF ANTIBIOTICS

Nano-guided cell networks as conveyors of molecular communication

(2015) Jessica L. Terrell et al.   Nature Communications

Bacterial Delivery of Staphylococcus aureus α-Hemolysin Causes Regression and Necrosis in Murine Tumors

(2014) Adam T St. Jean et al.   MOLECULAR THERAPY

A Predicted Immunity Protein Confers Resistance to Pyocin S5 in a Sensitive Strain ofPseudomonas aeruginosa

(2013) Bahareh Haji Rasouliha et al.   CHEMBIOCHEM

Shanghai fever: a distinctPseudomonas aeruginosaenteric disease

(2013) Chih-Hsien Chuang et al.   GUT

Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine

(2013) Rosalie Maltby et al.   PLoS One

Development of an HIV-1 Microbicide Based on Caulobacter crescentus: Blocking Infection by High-Density Display of Virus Entry Inhibitors

(2013) Christina Farr et al.   PLoS One

Genetically Programmable Pathogen Sense and Destroy

(2013) Saurabh Gupta et al.   ACS Synthetic Biology

Antimicrobial Peptides Targeting Gram-negative Pathogens, Produced and Delivered by Lactic Acid Bacteria

(2013) Katherine Volzing et al.   ACS Synthetic Biology

Engineering commensal bacteria for prophylaxis against infection

(2012) Yih-Lin Goh et al.   CURRENT OPINION IN BIOTECHNOLOGY

Enhanced Neutralization of HIV by Antibodies Displayed on the S-Layer of Caulobacter crescentus

(2011) Mark Duval et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen

(2011) N. Saeidi et al.   Molecular Systems Biology

Optimal regulatory strategies for metabolic pathways in Escherichia coli depending on protein costs

(2011) F. Wessely et al.   Molecular Systems Biology

BglBrick vectors and datasheets: A synthetic biology platform for gene expression

(2011) Taek Lee et al.   Journal of Biological Engineering

A predicted S-type pyocin shows a bactericidal activity against clinicalPseudomonas aeruginosaisolates through membrane damage

(2010) Hua Ling et al.   FEBS LETTERS

Translocation of Pseudomonas aeruginosa from the Intestinal Tract Is Mediated by the Binding of ExoS to an Na,K-ATPase Regulator, FXYD3

(2010) J. Okuda et al.   INFECTION AND IMMUNITY

Probiotic Escherichia coli strain Nissle 1917 outcompetes intestinal pathogens during biofilm formation

(2010) V. Hancock et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model

(2010) F. Duan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interdependence of Cell Growth and Gene Expression: Origins and Consequences

(2010) M. Scott et al.   SCIENCE

Precolonized Human Commensal Escherichia coli Strains Serve as a Barrier to E. coli O157:H7 Growth in the Streptomycin-Treated Mouse Intestine

(2009) M. P. Leatham et al.   INFECTION AND IMMUNITY

Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

(2009) T. K. Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical use of E. coli Nissle 1917 in inflammatory bowel disease

(2008) Michael Schultz   INFLAMMATORY BOWEL DISEASES

Refinement and standardization of synthetic biological parts and devices

(2008) Barry Canton et al.   NATURE BIOTECHNOLOGY